American pharma company Viatris to sell certain businesses for $3.4bn

By NS Healthcare Staff Writer

03 Oct 23

The drugmaker has received offer for its OTC business, and has agreed to divest its women's healthcare business,…

Patient CarePharmaceuticals and Medicines

UK’s MHRA approves Jemperli with chemotherapy in endometrial cancer treatment

By NS Healthcare Staff Writer

03 Oct 23

GSK’s Jemperli plus chemotherapy is now approved for patients with a tumour abnormality called mismatch repair deficient /…

Patient CarePharmaceuticals and Medicines

Novo Nordisk’s Rivfloza secures FDA nod for adults, children with PH1

By NS Healthcare Staff Writer

03 Oct 23

The approval was supported by the positive findings from the Phase 2 PHYOX 2 clinical trial and interim…

Patient CarePharmaceuticals and Medicines

SGC, HitGen collaborate on DEL technology for drug discovery

By NS Healthcare Staff Writer

29 Sep 23

HitGen will leverage its DNA-encoded library (DEL) technology platform for the collaboration, specifically the OpenDEL solution, a self-service…

Patient CarePharmaceuticals and Medicines

Amicus gets FDA approval for Pombiliti + Opfolda to treat Pompe disease

By NS Healthcare Staff Writer

29 Sep 23

The FDA has cleared the muscle disorder therapy only for adult LOPD patients whose weight is ≥40kg and…

Patient CarePharmaceuticals and Medicines

Scynexis recalls Brexafemme tablets over potential cross contamination risk

By NS Healthcare Staff Writer

29 Sep 23

Scynexis has recalled the drug over potential risk of cross contamination with a non-antibacterial ß-lactam drug substance in…

Patient CarePharmaceuticals and Medicines

FDA approves Fabre-Kramer’s Exxua for major depressive disorder

By NS Healthcare Staff Writer

29 Sep 23

The drug’s mechanism of targeted single serotonin (5HT) 1a receptor agonism reduced depressive symptoms with an acceptable side…

Patient CarePharmaceuticals and Medicines

Merck Receives Priority Review from FDA for New Biologics License Application for Sotatercept to Treat Adults with PAH

By NS Healthcare Staff Writer

29 Sep 23

If approved, sotatercept would be the first in its class, bringing a novel approach to address a rare…

Patient CarePharmaceuticals and Medicines

Viatris, Ocuphire get FDA approval for Ryzumvi eye drops to treat mydriasis

By NS Healthcare Staff Writer

28 Sep 23

The FDA approval was supported by the data from the MIRA trial programme in which the percentage of…

Patient CarePharmaceuticals and Medicines

US FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO for Maintenance Therapy in Moderately to Severely Active Ulcerative Colitis

By NS Healthcare Staff Writer

28 Sep 23

ENTYVIO Is the Only FDA-Approved Ulcerative Colitis Biologic That Offers the Choice of Intravenous or Subcutaneous Maintenance Therapy

Patient CarePharmaceuticals and Medicines